Loading your page…
Each register with its number of medicines and a few of them.
Health Canada · 2 medicines
EMA · 2 medicines
CBG-MEB · 2 medicines
Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.
AIFA · 1 medicine
SFDA · 1 medicine · Historical list
Every register, a page at a time. Strengths and packs are on each medicine’s page.
13 results
| Medicine | Register | Strength | Form | Status | Holder |
|---|---|---|---|---|---|
| Oritiniv | Canada | 1200 MG / VIAL | Powder For Solution | Authorised | Xediton Pharmaceuticals INC |
| Oritiniv | Canada | 400 MG / VIAL | Powder For Solution | Authorised | Xediton Pharmaceuticals INC |
| Tenkasi (previously Orbactiv) | European Union | Authorised | Menarini International Operations Luxembourg S.A. | ||
| Tenkasi 400 mg poeder voor concentraat voor oplossing voor infusie | Netherlands | Poeder voor concentraat voor oplossing voor infusie | Authorised | Menarini International Operations Luxembourg S.A. | |
| Tenkasi 1200 mg poeder voor concentraat voor oplossing voor infusie | Netherlands | Poeder voor concentraat voor oplossing voor infusie | Authorised | Menarini International Operations Luxembourg S.A. | |
| Tenkasi | Italy | Polvere per concentrato per soluzione per infusione | Authorised | Menarini International Operations Luxembourg S.A. | |
| Orbactiv | United States | 400MG BASE/VIAL | powder | Marketed | Melinta Therap |
| Kimyrsa | United States | 1.2GM BASE/VIAL | powder | Marketed | Melinta Therap |
| Tenkasi | Croatia | Authorised | |||
| Orbactiv | Saudi Arabia | Authorised | Patheon Italia S.P.A. | ||
| Ramvocid | European Union | Refused | Targanta Netherlands B.V. | ||
| Tenkasi 1200 MG Polvo Para Concentrado Para Solucion Para Perfusion | Spain | 1331,16 mg | polvo para concentrado para solución para perfusión | Marketed | Menarini International Operations Luxembourg S.A. |
| Tenkasi 400 MG Polvo Para Concentrado Para Solucion Para Perfusion | Spain | 443,7 mg | polvo para concentrado para solución para perfusión | Marketed | Menarini International Operations Luxembourg S.A. |
The same brand on several registers.
The companies holding its medicines, the most first.
How the registers write it, in their own languages.
Compiled by Prognia from the public medicine registers of AIFA, CBG-MEB, EMA, HALMED, Health Canada and SFDA. Each medicine’s page names its own source, licence and attribution.
Report an error or request removalCorrections from a register or a company are welcome.
For reference and learning, not treatment advice. Always check the official product information.
